Showing 1 - 10 of 23
Persistent link: https://www.econbiz.de/10003461955
Persistent link: https://www.econbiz.de/10003916101
Persistent link: https://www.econbiz.de/10001458589
Persistent link: https://www.econbiz.de/10001589562
Persistent link: https://www.econbiz.de/10001645039
Persistent link: https://www.econbiz.de/10011776439
Understanding how price regulations affect the adoption of new patent-protected pharmaceutical technologies is a crucial question in designing health systems. This paper addresses this question by examining how price expectations shape the probability of launch, controlling for competition,...
Persistent link: https://www.econbiz.de/10013067984
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...
Persistent link: https://www.econbiz.de/10013068052
This paper explores different empirical strategies to examine the effect of cost sharing for prescription drugs in some dimensions of medication-related quality, namely the probability of inappropriate prescription drug use among United States seniors. Using data from 1996 to 2005, we explore...
Persistent link: https://www.econbiz.de/10003951612
Understanding how price regulations affect the adoption of new patent-protected pharmaceutical technologies is a crucial question in designing health systems. This paper addresses this question by examining how price expectations shape the probability of launch, controlling for competition,...
Persistent link: https://www.econbiz.de/10009127576